Summary:
The difference between IH nuclear magnetic resonance (NMR) spectra obtained from the human brain during euglycemia and during hyperglycemia is depicted as well-resolved glucose peaks. The time course of these brain glucose changes during a rapid increase in plasma glucose was measured in four healthy subjects, aged 18-22 years, in five studies. Results demonstrated a signifi cant lag in the rise of glucose with respect to plasma glucose. The fit of the integrated symmetric Michaelis Menten model to the time course of relative glucose sig nals yielded an estimated plasma glucose concentration for half maximal transport, KI' of 4.8 ± 2.4 mM (mean ± SD), a maximal transport rate, Tma x , of 0.80 ± 0.45 fLmol g -) min -), and a cerebral metabolic glucose consump tion rate (CMR)glc of 0.32 ± 0. 16 fLmol g-I min-I. As-Human brain function depends upon a continu ous supply of glucose from the blood. The specific glucose transport mechanism from the blood has been shown to be of the insulin-independent facili tated diffusion type with saturation kinetics (Crone, 1965 ; for reviews see e.g. Pardridge 1983; Lund Andersen, 1979; Pelligrino et ai., 1992; Gjedde, 1992) and is mediated by transporter molecules (Mueckler et ai., 1985 ; Kalaria et ai., 1988) , mostly GLUT-l (Pardridge et ai., 1990) in the capillary en dothelial cells, referred to as the blood-brain barrier suming cerebral glucose concentration to be 1.0 fLmol/g at euglycemia as measured by 13C NMR, the fit of the same model to the time course of brain glucose concentrations resulted in Kt = 3.9 ± 0.82 mM, Tma x = 1. 16 ± 0.29 fLmol g-I min-I, and CMRglc = 0.35 ± 0. 10 fLmol g-I min-I. In both cases, the resulting time course equaled that pre dicted from the determination of the steady-state glucose concentration by 13C NMR spectroscopy within the ex perimental scatter. The agreement between the two meth ods of determining transport kinetics suggests that glu cose is distributed throughout the entire aqueous phase of the human brain, implying substantial intracellular con centration. Key Words: Glucose transport-Blood-brain barrier-Magnetic resonance spectroscopy-Human Michaelis-Menten. (BBB). Free glucose is measurable in animal brain (Gjedde and Diemer, 1983; Holden et aI., 1991; Ma son et ai., 1992) . Under physiological conditions, free glucose is measurable in the human brain (Gru etter et ai., 1992a) providing direct evidence that transport rates are in excess of the metabolic rate. Glucose transport may, however, become rate limiting to the metabolic rate in a variety of situa tions, such as hypoglycemia, seizures (Siesj6, 1978) , molecular defects of glucose transporter (De Vivo et ai., 1991) , hypoxic-ischemic encephalop athy, and Alzheimer's disease (Kalaria and Harik, 1989) . Quantitative measurements of glucose trans port using radioactive tracers have been difficult to interpret in humans (Brooks et ai., 1986; Feinende gen et ai., 1986; Gutniak et ai., 1990; Blomqvist et ai., 1991) , because the contribution of radiolabeled glucose or glucose analogs to the time course of measured tissue radioactivity needs to be deconvo luted from the accumulation of radioactivity in met abolic intermediates or products. It is well estab lished that the brain glucose concentration is a crit-ical parameter in the analysis of results from experiments using radiolabeled glucose or glucose analogs (Gjedde and Diemer, 1983; Gjedde 1982; Holden et aI., 1991; Sokoloff, 1984) .
A study performed in this laboratory by noninva sive B C nuclear magnetic resonance (NMR) deter mined the brain glucose concentration in humans to be 1. 0 ± 0. 1 fLmoIlml brain volume at euglycemia (Gruetter et aI., 1992a) . The kinetic parameters of glucose transport were determined by measuring the steady-state brain glucose concentration as a function of plasma glucose and by fitting the data to the symmetric Michaelis-Menten model of glucose transport (Lund-Andersen, 1979; Gjedde and Chris tensen, 1984) . This model assumes that the blood brain barrier is rate-limiting for glucose transport into the entire brain with transport from extracellu lar to intracellular space being relatively rapid.
A limitation of determining kinetic constants from the relationship between brain and plasma glu cose concentrations is the dependence upon the as sumption that the rate-limiting step for glucose transport into the brain cells is at the BBB. Alter natively, the rate-limiting step could be at the cell membrane, and the glucose measured by B C NMR is entirely within the extracellular space at near equilibrium with plasma glucose. In this case, intra cellular glucose would be zero and transport at the cell membranes would be rate-limiting for metabo lism. To test these possibilities, we derived brain glucose transport kinetics from the time course of the change in brain glucose measured by the more sensitive l H NMR difference spectroscopy after a rapid increase in plasma glucose concentration. The observed time course of changes in brain glucose concentration in the occipital lobe was compared directly to the time course predicted from the ki netic constants derived from steady-state measure ments of brain glucose concentrations (Gruetter et aI., 1992a) . Included are also some quantitative es timates of the contribution of the glucose signal to the 1 H NMR signal at euglycemia. A preliminary report has appeared previously (Novotny et aI., 1992) .
METHODS
All experiments were carried out on a 2. 1 Tesla whole body magnet (Oxford Magnet Technology , Oxford, Eng land) with an extensively modified Biospec spectrometer (Bruker-ORS , Billerica , MA, U.S.A.) equipped with an active-shielded gradient set (Oxford) of 72 cm clear diam eter. SUbjects were positioned in the supine position on an elliptic 6 x 7 cm diameter surface coil. Positioning was based on MR inversion recovery images-inversion time (TI) = 800 ms , echo time (TE) = 10 ms , repetition time (TR) = 2.5 s)-obtained as gradient echoes in sagittal and transverse planes. Localized automatic shimming was J Cereb Blood Flow Metab, Vol. 16, No.3, 1996 performed on all first-and second-order shim coils using FASTMAP (Gruetter , 1993) . A volume of 36 ml was lo calized in the occipital lobe of the brain using the pulse sequence described previously (Gruetter et aI. , 1992b) , with some modifications: Three-dimensional localization was obtained with ISIS (Ordidge et aI. , 1986) in conjunc tion with 5.5 ms phase-swept hyperbolic secant pulses (Silver et aI. , 1984; Baum et aI. , 1985) with I.L = 8 result ing in 4 kHz bandwidth. Outer volume suppression using 9-ms noise pulses (Connelly et aI. , 1988) was applied in the two planes perpendicular to the coil. The signal was de tected as a spin echo (TE = 16 ms) generated by a sinc pulse defined over ± 5'T1' exciting a slice parallel to the surface coil plane in conjunction with a semiselective bi nomial refocusing ex -Te -x pulse , where T was set to 5 ms. Use of the semiselective refocusing pulse separated the spatial and frequency selectivities and generated a positive amplitude throughout the spectrum (Blondet et aI. , 1987) . A e/3 pulse prior to the localization sequence was used to reduce signals from high B 1 flux regions (Shaka and Freeman , 1985) . Unwanted transverse co her ences were dephased by gradient pulses and surface gra dient spoiler pulses (Chen and Ackerman , 1989 ) through out the sequence. Longitudinal magnetization was mini mized after the data acquisition period of 256 ms by applying a 90° composite pulse (Levitt and Ernst , 1983) , i.e. , (e/2)x(e/2)/e/2)x(e/2Ly' Water suppression was achieved by the semiselective refocusing pulse and by low power pre saturation «0.2 Watts total) during the recovery delay , which was applied with a second low power amplifier through a directional coupler. In order to correct for field drift during blood sampling , spectra were collected in 3-min blocks (64 scans , 2.5 s repetition time). Difference spectra were obtained by extensive zero filling and corrected for frequency shifts only. Constant phase corrections were maintained throughout each study. Dif ference spectra were processed with Lorentzian-to Gaussian conversion (Gaussian factor = 0. 15, Lorentzian = -5Hz) plus baseline correction between 2.5 and 4.5 ppm and were expressed in % of the maximum increase , defined by the mean of the last four measurement points.
Catheters were placed into the left antecubital vein for the glucose infusion and the right upper extremity was catheterized to obtain blood samples. To aid with sam pling of arterialized blood , preheated saline bags were placed at the elbow and at the wrist. Plasma glucose con centrations were measured every 5 min in a Beckman glucose analyzer (Beckman , Fullerton , CA, U.S.A.) us ing the glucose oxidase technique. A variable priming in fusion of glucose, dextrose , 20% (wt/vol) was begun at t = 0 min so that the plasma glucose concentration was raised acutely and maintained -10 mM above baseline for 60 min according to previously described procedures (De Fronzo et aI. , 1979; Shulman et aI. , 1990) . A total of five studies were performed in four subjects (18-22 years). Full written informed consent was obtained prior to each study , which was approved by the Yale Human Investigations Committee. Sensory stimulation was min imized by having subjects wear eye patches and ear plugs.
Kinetic analysis of time courses
To analyze the time course of incremental brain glucose changes , we used the integrated symmetric Michaelis-Menten model of glucose transport (Lund Andersen , 1979; Carruthers , 1990) , shown in Fig. 1A .
This model assumes identical apparent Michaelis
Menten kinetics for both transport in , Tin , and out , Tout> of the brain. The model is entirely characterized by the apparent half-saturation constant K, (mM plasma glucose concentration) , the apparent maximal transport rate , T max (/Lmol g -1 min -I ) , the glucose consumption rate , CMRglc (/Lmol g-I min -I ) , and the distribution volume of glucose , Vd= 0.77 ml!g (Lund-Andersen , 1979; Gjedde and Diemer , 1983) . Using the kinetic constants of this model , the differential equation
describes the change in brain glucose Gbrain(t) (/Lmol!g) as a function of changes in plasma glucose Gplasma(t) (mM).
The time-independent form of this equation (Eq. 3) has been used in a number of studies to determine glucose transport kinetics from steady-state glucose measure ments in animal (e.g. , Gjedde and Christensen , 1984; and refs therein; Holden et aI. , 1990; Mason et aI. , 1992) and human brain (Gruetter et aI. , 1992a) .
T max represents the rate of product formation when the enzyme substrate complex concentration equals the total Blood Brain T out i CMS> :> G . I 8 A c enzyme concentration , E,o" In the present model , Tmax is , therefore , by definition a constant with respect to Gplasma' Conversely , K, is the Michaelis-Menten con stant , i.e. , the plasma glucose concentration at which the transport rate is half-maximal. Note that this model as sumes that the rate of product formation (transport of glucose into the brain) is not significantly product inhib ited. CMRg1 C is assumed to be constant since hexokinase is heavily saturated under the conditions of this study. An alteration of CMRglc through , e.g. , a change in V max' is unlikely based on the evidence of studies showing that net glucose uptake at hyperglycemia is constant (e.g. , Pap penheimer and Setchell , 1972). In addition , evidence from studies using 13C-labeled glucose and NMR from this brain region measured under identical experimental con ditions (Gruetter et aI. , 1994; Mason et aI. , 1995) show that at glycemia similar to that of this study , the measured CMRglc agrees with values obtained by other methods at euglycemia.
Equation 1 is justified from the Michaelis-Menten con dition , which requires the rate of the enzyme-substrate complex formation and breakdown to be fast compared to the rate of product formation (Mahler and Cordes , 1971) . A rise in plasma glucose from 5 to 15 mM in 10 min corresponds to change from 50 to 75% transporter satu ration (assuming a K, of �5 mM) , i.e. , a 2.5%/min rise , which is much slower than the 0.1 s of equilibration re-
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Ve Kt + G e FIG. 1. Models of glucose transport in the human brain. A: This model assumes that transport across the blood-brain barrier (BBB) is rate-limiting and that equilibration within the brain is fast, resulting in a single kinetic pool within the brain. Influx, T in' and efflux, Tout, across the BBB are characterized by Michaelis-Menten kinetics with identical kinetic constants, T max and K,.
Physical distribution volume of glucose is the entire aqueous phase of water, Vd = 0. 77 mllg (Eq. 1). B: In this model, intracellular glucose, Gi, is assumed to be 0 and extracellular glucose, Ge, in free exchange with plasma glucose, Go, using Fick's principle with an average CBF of 0. 5 ml/g -1 min -1 (Eq. 6). C: In this model, it was assumed that all of the brain glucose is in extracellular space (Ve = 0.2 mllg), but that glucose transport across the BBB is described by Michaelis-Menten kinetics using Eq. 1 with Vd = Ve= 0. 2 ml/g. In this case, T max/CMRglc is >25 given the concentrations reported by Gruetter et aI. , (1992a) . Ve was set to 0. 2 ml/g and Vi = Vd-Ve ported for endothelial cells (Gjedde and Christensen , 1984) suggesting that the rate of glucose-transporter com plex formation is several orders of magnitude faster than the rate of plasma glucose concentration change achiev able in humans.
Since changes in glucose concentration were mea sured, Eq. 1 was rewritten as
Differential brain glucose is given by 6Gbrain(t) = G brain(t) -Gg�ain and the initial steady-state brain glucose concentration Gg�ain is given by Eq. 3, the steady-state formulation of Eq. 1 at the initial plasma glucose concen tration G�lasma:
For numerical simulations , Eq. 2 was solved to give 6 Gbrain(t) using nonlinear methods with Gplasma(t) derived from the linear interpolation of the measured plasma glu cose concentrations. The term Vblood X 6Gplasma(t) was added to give the change in total observed glucose signal 6Gob s(t) , i.e., 6Gob s ( t) = 6Gbrain(t) + 6Gplasma(t) X Vblood (4)
to account for a small potential contribution of plasma glucose to the signal. Vblood was set to 0.035 ml/g based on position emission tomography (PET) and other mea surements of blood volume in human gray matter (Mar chal et aI. , 1992; Hino et aI. , 1992; Sabatini et aI. , 199 1).
The average of the last four time points of 6Gobs(t), i.e. ,
G�if,s was used to scale 6Gob s(t) to 100%, giving G�orm(t) (Eq. 5).
6Gobs (t)
Differential equations were solved using the Bulirsch Stoer algorithm (Press et aI., 1989) . All numerical solu tions were performed on a 16 MHz Zenith 386SX desktop computer equipped with a 387SX coprocessor using Turbo Pascal 6.0 Professional (Borland). In order to maintain computational efficiency , n � 3 variables fitted to the data.
In order to further evaluate the assumptions of the sym metric Michaelis-Menten model of glucose transport , e.g. , large physical distribution space and the rate limiting step for transport at the BBB , three models were tested as described in Fig. 1 ; the numerical analysis per formed is described below:
Model A: Symmetric Michaelis-Menten model (Fig. lAY . This model assumes that transport across the BBB is rate-limiting and equilibration within the brain is fast , re sulting in a single kinetic pool within the brain. Influx , Tin , and efflux , Tout , across the BBB are characterized by 1996 Michaelis-Menten kinetics with identical kinetic con stants , T ma x and Kt. Physical distribution volume of glu cose is the entire aqueous phase of water , V d = 0.77 ml/g (Eq. I). Fitting of the resulting Eq. 5 to the experimental time course was performed by minimizing the sum of squared residuals over a grid search of T ma x = 0.4 .. 1.6 fLmol g-I min-I , CMRglc= 0.20-0.50 fLmol g-I min-I , and Kt = 1.0 .. 8.0 mM. This fit was then compared with the values determined by the 13CMR experiments.
In a different analysis , we used the kinetic constants from the l3C NMR measurements (Gruetter et aI. , 1992a) to determine the initial and final glucose concentrations based on plasma glucose concentration. The time course of brain glucose Gobs(t) was then fitted based on Eq. 4 in order to assess whether this additional information im proved the precision of T ma x' and Kt, andCMRglc deter mination.
Model B: Fas t exchange between plasma and extracell ular glucose. An alternative explanation for the I3C NMR measurements is that the observed brain glucose enters the brain by rapid free diffusion only into the ex tracellular space. In this ml,ldel , intracellular glucose Gi is assumed to be zero and extracellular glucose Ge in free exchange with plasma glucose , Go , using Fick's principle , shown in Fig. 1B , by solving
instead of Eq. 1 and scaled analogously. As shown in Results , with an average CBF = 0.5 ml/g -I min -1 and an extracellular volume of 0.20 ml/g , the resulting time course of glucose in extracellular space follows closely that in plasma with a lag < 1 min. Model C: Michaelis-Menten kinetics for fast exchange at the BBB. In this model , it is assumed that all of the brain glucose is in extracellular space (Ve = 0.2 ml/g, G I = 0), but that glucose transport across the BBB is described by Michaelis-Menten kinetics using Eq. 1 with Vd = Ve = 0.2 ml/g as indicated in Fig. lC , assuming Gi = 0, i.e., Tout = 0, Tin = CMRglc. The previous quantifica tion by l3C NMR is , in that case , consistent with a lower limit for T ma x fCMRglc of 25, as derived by fitting Eq. 3 to the measured steady-state glucose concentrations given in Gruetter et al. (1993) . In these simulations T ma x i CMRglc = 25 was , therefore , assumed, resulting in a lag to plasma glucose that was similar to that in model B, i.e. , 1 min.
Calculation of the dis tribution space of glucose. In a fourth set of simulations , we fitted V d in Eq. 1, instead of CMRglc , which was set to 0.35 fLmol g-I min -I, based on previous measurements in the occipito-parietal region by radioisotope methods (Heiss et aI. , 1984; Tyler et aI. , 1988) and by l3C NMR (Gruetter et aI. , 1994; Mason et aI. , 1995) . For this purpose , the differential Eq. 4 was fitted to the change in brain glucose expressed in fLmolig , as described in model A. The minimization of x2 was performed using the direction set (Powell) method (Press et aI. , 1989) .
RESULTS

Assignment of in vivo glucose resonances
Measurement of the brain glucose concentrations by localized l 3e NMR had the advantage of being a direct quantitative measurement of well-resolved peaks, albeit with relatively low spatial and tempo ral resolution. In another study, we showed that I H NMR difference spectroscopy can be used to mea sure changes in brain glucose content after a rapid increase in plasma glucose (Gruetter et aI., 1991; Gruetter et aI., 1992b; Gruetter et aI., 1993) with much higher sensitivity than 13C NMR. Figure 2A shows regions of short-echo lH NMR spectra (TE = 16 ms) obtained at euglycemia (4.8 mM) and hyperglycemia (18 mM) during a study. The dominant resonance was that of H20 at 4.72 ppm. At hyperglycemia, significant signal increases were seen at 5.23, 3.81, and 3.44 ppm in the spectra, as indicated by the dotted vertical lines. The corre sponding difference spectrum is shown in Fig. 2B and is compared to a spectrum of a phantom, con taining equimolar creatine and glucose [�150 mM phosphate buffer (pH 7.1), 2 mM NaN 3 , 10 mM acetate, T 37°C]. The solution spectrum was line broadened to match in vivo creatine linewidths. Chemical shifts and relative amplitudes in the in vivo difference spectrum (Fig. 2B ) corresponded to those of glucose in the line broadened solution spec tra.
Assessment of spectral overlap
Although measurement of total brain glucose lev els by lH NMR has been attempted without taking into account contributions of other compounds to the NMR signal (Gyngell et aI., 1991; Merboldt et aI., 1992; Kreis and Ross, 1992) , direct measure ment is difficult due to overlap with resonances of other brain metabolites, in contrast to difference spectra, which are well resolved (Gruetter et aI., 1992b) .
While increments of glucose concentrations are measurable from the difference spectra, the direct quantification of glucose by I H NMR spectroscopy is hampered by the close proximity of the water signal and by overlap with resonances from taurine, inositol, glutamate, and glutamine, all of which are more concentrated than is glucose in the brain (Petroff et aI., 1989) . At 3.44 ppm overlap from tau rine and myo-inositol can be expected at 2.1 Tesla based on chemical shifts, coupling patterns, and concentrations in human brain. The average in crease of plasma glucose, from 5 to 17 mM, doubled the amplitude at 3.44 ppm. From the 13C NMR measurement of brain glucose (Gruetter et aI., 1992a) , this corresponds to a 2.8 J-Lmollml brain vol ume change in brain glucose concentration, sug gesting that � 1/, of the amplitude in the euglycemic spectrum is due to glucose.
To estimate the contribution of myo-inositol at The difference spectrum was obtained by correct ing for field drift only, i.e., by shifting the zero-filled spectra digitally. The solution spectrum (top) was obtained under identical experimental conditions from a preheated 2 L bottle placed on the surface coil containing glucose and equimolar creatine, �150 mM phosphate buffer (pH 7.1, 37"C) , and 10 mM acetate plus 2 mM NaN3. The solution spectrum was line broadened until the line width of acetate matched that of singlets (Cr, NAA) in the in vivo spectra. Assignments (major constituents): 1: (phospho)creatine CH2, 2: aH protons of amino acids, 3: myo-inositol, 4: choline and other trimethyl amine resonances, 5: (phospho)creatine CH3. N-acetyl aspartate at 2.02 ppm (not shown) was used as chemical shift reference.
the 3.44 ppm glucose resonance, the myo-inositol solution spectrum was subtracted from the in vivo spectrum (Fig. 3) . The subtraction was performed interactively using standard spectrometer software (DISR88) and minimized the amplitude at 3.57 ppm to 7 ± 5% of its original value (mean ± SD). An analysis of five 15-min spectra yielded a concomi- tant 55 ± 3% (mean ± SD) decrease in amplitude at the glucose position (3.44 ppm). Note that the shape and area of the trimethylamine peak (peak 4 in Fig.  3) is affected by the contributions of myo-inositol, reducing an apparent asymmetry. That contribution is from the triplet of H2 of myo-inositol at this field strength. Elevated IH NMR glucose resonances in patients with hyperglycemia due to diabetes have been re ported previously at this chemical shift (Michaelis et aI., 1991) . However, poor correlation between glycemia and the signal area at 3.44 ppm was found in the study by Kreis and Ross, (1992) . Our at tempts to further resolve that spectral region (Fig.  3) indicate that a substantial nonglucose signal is present at 3.44 ppm, stemming predominantly from myo-inositol, as confirmed by measuring at echo TEs of 16-160 ms (not shown). The majority, i.e., half of the amplitude at euglycemia is from myo inositol and we estimate, based on the predicted value from 13e NMR, that just one-third of the am plitude is from glucose. A tight correlation between steady-state brain glucose concentration and plasma glucose, however, was observed by 13e NMR in normal and diabetic humans (Novotny et aI., 1993) . The low degree of correlation between plasma glu cose and brain glucose signal in IH NMR spectra of diabetics reported by others hence may J Cereb Blood Flow Metab, Vol. 16, No.3, 1996 have been due to vanatlOns in overlapping myo inositol resonances, levels of which have been shown to change in diabetes (Stewart et aI., 1967) .
Time course of observed brain glucose concentration during infusion
During the intravenous infusions of glucose, dif ference spectra were obtained at 4-5 min intervals. Figure 4 shows the time course of difference spectra from one study. Both the 3.81 and 3.44 ppm glucose peaks are clearly discernible and well resolved from other background resonances, which are com pletely subtracted over the entire time period. The pulse sequence and shimming used resulted in a highly stable baseline, water suppression, and a fre quency selective amplitude. To obtain the time courses for kinetic analysis, spectra were processed with Gaussian multiplication and the amplitude was measured at 3.44 ppm in baseline-corrected differ ence spectra. Both parts of Fig. 5 show the time course of plasma and brain glucose of volume of 0.035 ml/g (Eq. 5). The dashed line (which almost completely overlaps the solid line) is the best fit of the model to the time course of this study. In Fig. 5B , the solid line is the expected time course assuming brain glucose in extracellular space (�20% of brain volume) to be in free ex change with blood. The solid line parallels the change in plasma glucose, which is inconsistent with the experimental observation. The dashed line is the time course derived by assuming Michaelis Menten kinetics at the BBB with all glucose being in extracellular space, for which T max/CMRg\c must be >25, based on the previous quantification of brain glucose (see methods and below).
Assessment of transport kinetics
The kinetic analysis distinguished several possi bilities, as described in methods:
Model A: Symmetric Michaelis-Menten model. Based on the aforementioned difficulties in measur ing steady-state glucose concentrations directly by IH NMR, we used relative glucose signal increases to derive experimental fits of Eq. 5 to obtain kinetic constants (Fig. 5) . A plasma glucose concentration of half-maximal transport Kt = 4.8 ± 2.4 mM (mean ± SD), a maximal transport rate of T max = 0.80 ± 0.45 fLmol g -I min -I, and a glucose consumption rate of CMRg\c = 0.32 ± 0.16 fLmol g-l min-I were obtained from the fit of Eq. 5 to the five studies (row 1 in Table O .
Since we established, in a previous study, that cerebral glucose concentration is 1.0 ± 0.1 fLmol/g (mean ± SEM) at euglycemia, we also solved for time course by replacing signal increases with this initial euglycemic glucose concentration and by us ing the final glucose concentration obtained by ex trapolating to the corresponding final plasma glu cose concentration from Gruetter et al. (1992a) . The resulting constants were Kt= 3.90 ± 0.82 mM (mean ± SD), a maximal transport rate of T max = 1.16 ± 0.29 fLmol g -I min -I, and glucose consump tion rate of CMRg\c = 0.35 ± 0.10 fLmol/g (row 2 in Table 1 ).
(Model AI-A3) The effect of assuming different euglycemic glucose concentrations on T max and Kt was judged by varying Gg�a in within the 95% confi dence interval (rows 3-5 in Table 1 ), i.e., between 0.8 and 1.2 mM, within which Kt varied by 8Kt = (i) _ ( i ) 1.5x8G brain and Tmax by 8Tmax -0.45 x8 G brain . These variations are within the experimental error.
In order to evaluate the possibility that intracel lular glucose is 0 (G I = 0), two cases were solved: Model B: Fast exchange between plasma and extracellular glucose. The assumption that intracel lular glucose is 0 (G i = 0) (see methods) results in Values are given as mean ± SD if fitted, fixed parameters are indicated without error. In order to maintain computational efficiency, n �3 variables fitted to the data.
a Equivalent to mlll00g. b The fit was performed constrained, i.e., in one study, Vd was set to its maximum, 0.965 mllg.
glucose time courses that parallel the plasma time course closely in the case of free diffusion (solid line in Fig. 5B ). This observation is consistent with the estimation that with an average cerebral blood flow of 0.5 ml/g min the glucose influx into the human brain is 2.5 j-lmol g -I min -I , for an increase from 5 to 10 mM plasma concentration, which exceeds the reported change in glucose concentration (Gruetter et aI., 1992a) .
Model C: Michaelis-Menten kinetics for fast ex change at the BBB. When all the glucose is assumed to be confined to the extracellular space (�0.2 mIl g), glucose concentrations that we reported by l 3 C] NMR (Gruetter et aI., 1992a; Gruetter et aI., 1993) resulted in a T max/CMRglc > 25 when fitting the Michaelis-Menten model with Vd = Ve = 0.2 ml/g (not shown). Assuming Gj = 0 and Michaelis Menten kinetics at the BBB (Fig. lC) with V d = 0.20 mlig, T max/CMRglc = 25 or (virtually any range of T max/CMRglc) gave time courses that closely par alleled plasma glucose as illustrated by the dashed line in Fig. SB. The measured time courses, however, contained only a very small fraction of the signal that parallels the plasma glucose, as shown by fitting Vblood in stead of CMRglc (row 6 in Table 1 ), which is con sistent with only a small signal fraction being from the blood compartment.
Calculation of the distribution space of glucose. Since models B and C, which assumed a small dis tribution space of glucose, are inconsistent with the lag in brain glucose observed, Vd in Eq. 1 was also fitted as follows:
We fitted Vd to the time courses, assuming con centrations based on the previous quantification (as in model A) and setting Vblood = 0.035 ml/g and CMRglc = 0.35 j-lmol g -I min -I (based on previous measurements of this region of the brain) (Heiss et aI., 1984; Tyler et aI., 1988) . The result of this cal culation was Kt= 3.5 ± 0.9 mM (mean ± SD), Tmax= 1.11 ± 0.25 j-lmol g-I min-I, and Vd= 0.77 Vol. 16, No.3, 1996 ± 0.01 mllg (n = 4). In one study, Vd was 2.1 mlig, which is above the physical upper limit of 0.965 ml/g. Using, for that study, V d = 0.965 ml/g gave an average Vd = 0.81 ± 0.09 mllg (n = 5, row 7 in Table 1 ), which is within the experimental error identical to the distribution space of water, i.e., 0.77 mlig.
DISCUSSION
Previous measurements of steady-state human cerebral glucose concentrations by l 3 C NMR gave a concentration of 1 j-lmol/ml brian volume at eu glycemic (4.8 mM) plasma concentration (Gruetter et aI., 1992a) . This direct brain glucose measure ment was also consistent with all of the brain glu cose being in extracellular space, which comprises � 20% of total brain volume (Lund-Andersen, 1979) at a concentration equal to that of plasma glucose. In that extreme case, glucose concentration in the brain cells would be close to zero and transport across the brain cell membranes would be rate limiting for phosphorylation of glucose. Such a sit uation is consistent with the observation of satura tion kinetics for 2-deoxyglucose transport in brain slices (Bachelard, 1971) . Later evidence, however, argued in favor of a very rapid equilibration of glu cose in the aqueous phase of animal brain based on diffusion measurements of glucose analogs (Lund Andersen, 1979) , distribution volumes of glucose (Holden et aI., 1991) , and glucose analogs (Gjedde and Diemer, 1983 ), suggesting that the BBB is rate limiting for glucose transport, but not phosphoryla tion. In addition, previous direct l3C NMR mea surements of total rat brain glucose concentration (Mason et aI., 1992) are similar to very recent mea surements of extracellular glucose concentration using microelectrodes (Silver and Erecinska, 1994) suggesting that concentrations of intra-and extra cellular brain glucose are similar in rat brain. The present results argue in favor of a similar situation in the human brain in vivo under normal physio logic conditions, since this study demonstrates a significantly delayed rise in brain glucose relative to plasma glucose, indicating saturation kinetics and a large physical distribution space of glucose in hu man brain (row 7 in Table 1 ).
The parameters for glucose transport obtained from the time courses of plasma glucose increments (row 1 in Table 1 ) are similar to those reported pre viously from the relationship of plasma glucose ver sus brain glucose at steady-state (Gruetter et ai., 1992a) . Both approaches used the symmetric Michaelis-Menten model for glucose transport across the BBB to calculate the kinetic constants. The kinetic parameters of steady-state glucose transport obtained by B C NMR spectroscopy pre dict the time course of brain glucose increments accurately, as illustrated in Fig. 5A , further empha sizing the consistency of the experimental evi dence. Comparison of this study with previous mea surements of brain glucose transport in humans us ing radioisotope methods (Table 2) shows that the Kt values are highly consist"'nt among the different methods used and falls slightly below the normal fasting glucose concentration. However, as shown in Table 2 , T max values obtained by radioisotope methods scatter by a fivefold range. Euglycemic brain glucose concentrations calculated from the symmetric transport model (Eq. 3), using the re spective kinetic constants given in columns 4 and 5 in Table 2 and the accepted standard of 0.3 J-lmol g-l min-1 for CMRglc for gray matter (Heiss et ai., 1984; Tyler et ai., 1988) , range thus from -0.6 to 2 J-lmol/g (column 6 in Table 2) , with none of the pre vious studies being consistent with the NMR mea surement (row 5 in Table 2 ). This discrepancy be comes more apparent when comparing direct in vivo NMR quantification at 10 mM plasma glucose concentration with predicted values from isotope measurements (column 7 in Table 2 ): Three of the four PET studies predict glucose concentrations be low the euglycemic NMR value. If the Km for hexo kinase is assumed to be on the order of 50 J-lM, then it is clear that the brain glucose concentrations de rived from these studies predict that brain glucose transport is rate-limiting for metabolism at euglyce mia in contrast to the conclusion of the present re port.
It is well established that glucose transport is mediated by glucose transporters, which are a hom ologous class of transmembrane proteins with transporter-type and species-specific differences (Mueckler, 1994) . Most of the present evidence sug gests that the erythrocyte/liver type glucose trans porter, GLUT-I, is the abundant transporter mole cule at the membranes of the endothelial cells com prising the BBB (Pard ridge et ai., 1990). A different, recently identified, brain-type glucose transporter, GLUT-3, (Gerhart et ai., 1992) seems to be distrib uted mainly within brain tissue that has little mea surable GLUT-l (Maher et ai., 1993; Mantych et ai., 1992) . The evidence we obtained suggests that the BBB is the major rate-limiting step for glucose entry into human brain, with an overall higher transport capacity at the intracellular/extracellular interface compared to that at the BBB. Even though transport rates within the brain might be extremely high, leading to a single, well-mixed brain glucose pool, the transport rate will be limited by the slow est step of the mUltiple sequential transport steps, which we propose in the human brain to be at the BBB.
We have obtained IH NMR spectra of glucose from the brain of healthy volunteers by taking the difference between spectra obtained at euglycemia and during a glucose infusion. Since these differ ence spectra contain only signals from glucose, the high sensitivity of IH NMR allowed measurement of changes in glucose levels with 3-min time reso lution. The noninvasive, time-resolved measure- a Brain glucose concentrations were calculated at a plasma glucose concentration of 4.8 mM from the given transport constants using Eq. 3 and assuming a CMRglc of 0.3 fJ-mol/g-I min -I (Heiss et at., 1984) .
b Derived at a plasma glucose of 10 mM as in footnote a.
C Constants from this study are inconsistent with a positive brain glucose concentration at euglycemia. d Derived by fitting kl = T max/(K, + Gplasma) to kl measured at two different Gplasma' e Brain glucose concentration was measured directly in this study. ment of brain glucose changes from small volumes by IH NMR opens the prospect of measuring glu cose transport and rates of glycolysis noninva sively; decreases in brain glucose concentrations have been reported using IH NMR during brain vi sual activation (Merboldt et aI., 1992; Chen et aI., 1993) . Observations of the (resolved) "'HI reso nance at 5.23 ppm, as indicated in the difference spectrum (Fig. 2B) , may become a routine method to quantify cerebral glucose, particularly at hyper glycemia. Alternatively, it has been shown in cat brain that measurement of the HI proton coupled to the CI carbon can be measured during [1-13C] glu cose infusions, when using strong gradients and multiple-quantum coherence to eliminate the water signal, with a sensitivity that may be sufficient to measure glucose influx rates and spatial distribution during hyperglycemia (van Zijl et aI., 1992; In ubushi et aI., 1993; van Zijl et aI., 1993) . Using ei ther method, from the subsequent difference spec tra it may, thus, be possible to deduce cerebral glu cose concentrations at lower plasma glucose concentrations. Simulations based on the I3C NMR quantification of cerebral glucose indicate that mea surement of the cerebral glucose concentration con siderably improves the accuracy of the determina tion of transport kinetics.
Conclusions
This study confirms our earlier observations that difference IH spectroscopy is a useful tool to inves tigate glucose transport in the human brain since these difference spectra contain only intensity from glucose. As such, NMR is to date the only method that permits noninvasive measurement of cerebral glucose in human brain under physiological condi tions.
The direct measurement of glucose concentration and, potentially, transport and metabolism by I H NMR spectroscopy adds to existing measurements of PET, indicator-dilution, and other techniques since it does not use ionizing radiation and is less invasive. Hence, NMR may be a useful and cost effective alternative to PET for certain studies such as longitudinal and pediatric studies.
The time course of the brain glucose difference is consistent with the previous determination of BBB transport kinetics by 13C NMR in humans (Gruet ter et aI., 1992a) . The large distribution space de rived from the present study indicates that intracel lular and extracellular glucose levels are similar in the human brain. The implied rapid transport rates within the brain suggest that transport across the BBB is the rate-limiting step of the multiple steps involved in glucose transport. Demonstration of a J Cereb Blood Flow Metab, Vol. 16, No.3. 1996 significant brain glucose concentration is direct ex perimental evidence that glucose transport is not rate-limiting for metabolism, which suggests that glucose transport does not regulate human brain glucose metabolism.
